(March 03 03:29) Forbes.com Business
The Food and Drug Administration turned down a bid from Neuralink, the ambitious yet controversial human brain chip startup founded by the nation’s richest man Elon Musk, to begin human trials, Reuters reported Thursday.
You can find the original article
here